FrancophonIA/ELRC3.0 huggingface dataset:
English: The Insulin lispro Sanofi cartridges should only be used with the following pens: - JuniorSTAR which delivers Insulin lispro Sanofi in 0.5 unit dose increments - Tactipen, AllStar and AllStar PRO which all deliver Insulin lispro Sanofi in 1 unit dose increments.
Maltese: - JuniorSTAR li tagħti Insulin lispro Sanofi b'żidiet ta' 0.5 unità fid-doża Tactipen, AllStar u AllStar PRO , li kollha jagħtu Insulin lispro Sanofi b'żidiet fid-doża ta' unità 1.
English: • not using your Insulin lispro Sanofi or other insulin;
Maltese: • ma tużax Insulin lispro Sanofi jew insulina oħra;
English: Plunger
Maltese: Planġer*
English: NAME OF THE MEDICINAL PRODUCT Insulin lispro Sanofi 100 units/ml solution for injection in vial Insulin lispro Sanofi 100 units/ml solution for injection in cartridge Insulin lispro Sanofi 100 units/ml solution for injection in a pre-filled pen
Maltese: Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni f'kunjett Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni f'pinna mimlija għal-lest
English: • Always keep spare syringes and a spare vial of Insulin lispro Sanofi
Maltese: • Dejjem żomm siringi żejda u kunjett żejjed ta' Insulin lispro Sanofi
English: A consequence of the pharmacodynamics of rapid-acting insulin analogues is that if hypoglycaemia occurs, it may occur earlier after an injection when compared with soluble human insulin.
Maltese: Konsegwenza tal-farmakodinamika tal-analogi tal-insulina li taġixxi malajr hija li jekk ikun hemm ipogliċemija, din tista' titfaċċa aktar kmieni wara injezzjoni meta mqabbla ma' insulina umana li tinħall.
English: It works more quickly than normal human insulin because the insulin molecule has been changed slightly.
Maltese: Huwa jaħdem aktar malajr minn insulina umana normali minħabba li l-molekula tal-insulina ġiet mibdula kemxejn.
English: If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) is not treated, they can be very serious and cause headaches, feeling sick (nausea), being sick (vomiting), loss of fluids (dehydration), unconsciousness, coma or even death (see Hypoglycaemia and Hyperglycaemia and diabetic ketoacidosis in section 4 “Possible Side Effects”).
Maltese: Jekk l-ipogliċemija (zokkor baxx fid-demm) jew l-ipergliċemija (zokkor għoli fid-demm) ma tkunx ittrattata, huma jistgħu jkunu serji ħafna u jikkawżaw uġigħ ta' ras, dardir (nawsja), rimettar, telf ta' fluwidi (deidratazzjoni), telf mis-sensi, koma kif ukoll mewt (ara Ipogliċemija u Ipergliċemija u ketoaċidożi tad-dijabete fis-sezzjoni 4 “Effetti Sekondarji Possibbli”).
English: Other medicines and Insulin lispro Sanofi
Maltese: Mediċini oħra u Insulin lispro Sanofi
English: Important information about some of the ingredients of Insulin lispro Sanofi This medicine contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially “sodium-free”.
Maltese: Informazzjoni importanti dwar xi whud mis-sustanzi ta' Insulin lispro Sanofi Din il-mediċina fiha inqas minn 1 mmol (23 mg) sodium f'kull doża, i.e. hija essenzjalment “mingħajr sodium”.
English: Common problems of diabetes
Maltese: Problemi komuni tad-dijabete
English: Within muscle tissue this includes increasing glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake, while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis, protein catabolism and amino acid output.
Maltese: Fit-tessut tal-muskolu dan jinkludi ż-żieda fis-sintesi tal-glycogen, tal-aċidi grassi, tal glycerol u tal-proteini u l-assorbiment tal-aċidu amminiku, filwaqt li jkun hemm tnaqqis filglikoġenolisi, fil-glukoneoġenesi, fil-ketoġenesi, fil-lipoliżi, fil-kataboliżmu tal-proteini u filproduzzjoni tal-aċidu amminiku.
English: Insulin lispro Sanofi with alcohol
Maltese: Insulin lispro Sanofi mal-alkoħol
English: Hypersensitivity to insulin lispro or to any of the excipients listed in section 6.1.
Maltese: Sensittività eċċessiva għal insulin lispro jew għal kwalunkwe wieћed mill-eċċipjenti elenkati fissezzjoni 6.1.
English: Insulin lispro Sanofi 100 units/ml solution for injection in a pre-filled pen Type 1 colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with a sealing disk (laminate of isoprene and bromobutyl rubber) sealed in a disposable pen injector (SoloStar).
Maltese: Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ Skartoċċ tal-ħġieġ tat-tip I bla kulur bi planġer iswed (lastku bromobutyl) u għatu flanġ (aluminju) b'diska li tissiġilla (laminat ta' lastku isoprene u bromobutyl).
English: Lipodystrophy
Maltese: Ipogliċemija
English: Before the first use store your Insulin lispro Sanofi in a refrigerator (2°C - 8°C).
Maltese: Qabel tużah l-ewwel darba aħżen Insulin lispro Sanofi fil-friġġ (2°C - 8°C).
English: Insulin lispro Sanofi 100 units/ml solution for injection in vial Each vial contains 10 ml equivalent to 1,000 units insulin lispro.
Maltese: Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni f'kunjett Kull kunjett fih 10 ml ekwivalenti għal 1,000 unità insulin lispro.
English: Insulin lispro Sanofi 100 units/ml solution for injection in cartridge Each cartridge contains 3 ml equivalent to 300 units insulin lispro.
Maltese: Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ Kull skartoċċ fih 3 ml ekwivalenti għal 300 unità insulin lispro.
English: Do not use Insulin lispro Sanofi in a pre-filled pen after the expiry date which is stated on the label and the carton.
Maltese: Tużax Insulin lispro Sanofi wara d-data ta' meta tiskadi li tidher fuq it-tikketta u l-kartuna.
English: Insulin lispro Sanofi 100 units/ml solution for injection in cartridge Insulin lispro
Maltese: Insulin lispro Sanofi 100 unità/ml injezzjoni fi skartoċċ Insulin lispro
English: • rapid heartbeat
Maltese: • tħossok imdardar
English: Insulin lispro Sanofi 100 units/ml solution for injection in vial Type I colourless glass vial with a flanged cap (aluminium) with a sealing disk (chlorobutyl rubber) and a tear-off cap (polypropylene) containing 10 ml of solution.
Maltese: Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni f'kunjett Kunjett tal-ħġieġ tat-tip I bla kulur b'għatu flanġ (aluminju) b'diska li tissiġilla (lastku chlorobutyl) u tapp li jitqaċċat (polypropylene) li fih 10 ml ta' soluzzjoni.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution contains 100 units (equivalent to 3.5 mg) insulin lispro*.
Maltese: Millilitru wieħed ta' soluzzjoni fih 100 unità (ekwivalenti għal 3.5 mg) insulin lispro*.
English: A few patients who have experienced hypoglycaemic reactions after transfer from animal-source insulin to human insulin have reported that the early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin.
Maltese: • Xi ftit nies li kellhom ipogliċemija wara li qalbu minn insulina tal-annimali għal insulina umana rrappurtaw li l-ewwel sintomi ta' twissija kienu anqas ovvji jew differenti.
English: One ml solution contains 100 units (equivalent to 3.5 mg) insulin lispro.
Maltese: Millilitru ta' soluzzjoni fih 100 unità (ekwivalenti għal 3.5 mg) ta' insulina lispro.
English: 10 pens of 3 ml
Maltese: 10 pinen ta' 3 ml
English: Marketing Authorisation Holder: sanofi-aventis groupe, 54 rue La Boétie, F - 75008 Paris, France
Maltese: Detentur tal-Awtorizzazzjoni għat-Tqegħid fis-Suq: sanofi-aventis groupe, 54 rue La
English: Insulin lispro Sanofi 100 units/ml solution for injection in vial Store in a refrigerator (2°C - 8°C).
Maltese: Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni f'kunjett Aħżen fi friġġ (2°C - 8°C).
English: Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Maltese: episodji frekwenti ta' ipogliċemija sinjali ta' twissija mnaqqsa jew assenti ta' ipogliċemija
English: The physician should be consulted when using other medicinal products in addition to Insulin lispro Sanofi (see section 4.4).
Maltese: Għandu jkun ikkonsultat it-tabib meta jintużaw prodotti mediċinali oħra flimkien ma' Insulin lispro Sanofi (ara sezzjoni 4.4).
English: • Keep new pens in a fridge, at 2°C to 8°C.
Maltese: • Żomm il-pinen il-ġodda fil-friġġ, f'temperatura bejn 2°C u 8°C.
English: • you inject too much Insulin lispro Sanofi or other insulin;
Maltese: • inti tinjetta wisq Insulin lispro Sanofi jew insulina oħra;
English: Insulin lispro Sanofi 100 units/ml solution for injection in a pre-filled pen Store in a refrigerator (2°C - 8°C).
Maltese: Insulin lispro Sanofi 100 unità/ml soluzzjoni għall-injezzjoni fi skartoċċ Aħżen fi friġġ (2°C - 8°C).
English: EU/1/17/1203/003 1 pen.
Maltese: EU/1/17/1203/001-008
English: • angiotensin II receptor blockers.
Maltese: • sustanzi li jimblukkaw ir-riċetturi ta' anġjotensin II.
English: The Insulin lispro Sanofi in a pre-filled pen (SoloStar) comes in a pack of 1, 3, 5 or 10 pre-filled pens.
Maltese: Il-pinna mimlija għal-lest Insulin lispro Sanofi (SoloStar) tiġi f'pakketti ta' pinna 1, 3, 5 jew 10 pinen mimlijin għal-lest.
English: Thighs
Maltese: Treddigħ
English: Injecting Insulin lispro Sanofi
Maltese: X'fih Insulin lispro Sanofi
English: • Use a clean needle.
Maltese: • Uża labra nadifa.
English: 3 pens of 3 ml
Maltese: 3 pinen ta' 3 ml
English: D Pull off the inner needle cap and throw away.
Maltese: Inti għandek tużaha biss jekk jidher qisu ilma.
English: Each cartridge contains 3 ml of solution for injection, equivalent to 300 units.
Maltese: Kull skartoċċ fih 3 ml ta' soluzzjoni għall-injezzjoni, ekwivalenti għal 300 unità.
English: EXP
Maltese: Mard
English: Put the needle through the rubber top of the Insulin lispro Sanofi vial and inject the air into the vial.
Maltese: • Dejjem żomm siringi żejda u kunjett żejjed ta' Insulin lispro Sanofi, jew pinna u skrataċ żejda,
English: Pen cap
Maltese: Wara li tinjetta
English: Subcutaneous administration of Insulin lispro Sanofi
Maltese: Jekk tinsa tuża Insulin lispro Sanofi
English: METHOD OF ADMINISTRATION Use specific pens.
Maltese: Tinjettax direttament ġo vina.
English: The reduction of HbA1c would also be expected with other insulin products e.g. soluble or isophane insulins.
Maltese: It-tnaqqis fl-HbA1c huwa mistenni wkoll bi prodotti oħra tal-insulina eż. insulini li jinħallu jew isophane.
English: In patients with type 2 diabetes over a wide range of renal function the pharmacokinetic differences between insulin lispro and soluble human insulin were generally maintained and shown to be independent of renal function.
Maltese: F'pazjenti bid-dijabete tat-Tip 2 fuq firxa wiesa' ta' funzjoni talkliewi d-differenzi farmakokinetiċi bejn l-insulina lispro u l-insulina umana li tinħall kienu ġeneralment miżmuma, u ntwerew li huma indipendenti mill-funzjoni tal-kliewi.
English: Medicinal product subject to medical prescription.
Maltese: Ġib għajnuna medika immedjatament.
English: Insulin lispro Sanofi 100 units/mL solution in a pre-filled pen
Maltese: Insulin lispro Sanofi 100 unità/mL soluzzjoni f'pinna mimlija
English: For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
Maltese: Għall-kura ta' adulti u tfal bid-dijabete mellitus li għandhom bżonn l-insulina għall-manteniment omeostatiku ta' livelli normali ta' glukożju.
English: Dose window Dose pointer
Maltese: Meta tarmi l-pinna tiegħek
English: After first use Dispose of after 4 weeks.
Maltese: A Iċċekkja l-isem u d-data ta' meta tiskadi fuq it-tikketta tal-pinna tiegħek.
English: Do not overtighten.
Maltese: Twissijiet u prekawzjonijiet
English: • feeling sick
Maltese: • uġigħ ta' ras
English: - Dantrolene (infusion)
Maltese: - Dantrolene (infużjoni)
English: digoxin, warfarin or ciclosporin.
Maltese: digoxin, warfarin jew ciclosporin.
English: Absolute bioavailability has been estimated as between 64% and 80%.
Maltese: Il-bijodisponibbiltà assoluta kienet stmata bejn 64% u 80%.
English: Metabolic and endocrine effects
Maltese: Effetti metaboliċi u endokrinarji
English: - CYP450 interactions
Maltese: - Interazzjonijiet ma' CYP450
English: Cellulose microcrystalline Crospovidone Povidone
Maltese: Qalba tal-pillola Cellulose microcrystalline Crospovidone Povidone
English: - Amantadine
Maltese: - Amantadina
English: Circulating hydrochlorothiazide is bound to serum proteins (40-70%), mainly serum albumin.
Maltese: Hydrochlorothiazide li jiċċirkola huwa mwaħħal ma' proteini tas-serum (40-70%), l-aktar mal-albumina tas-serum.
English: Contraindicated (see section 4.3) - Dual RAAS blockade
Maltese: Kontraindikat (ara sezzjoni 4.3) - Imblokk doppju ta' RAAS
English: IT-80058 Torre Annunziata
Maltese: I-80058 Torre Annunziata/NA L-Italja
English: Visual disturbance (including diplopia)
Maltese: Disturb fil-vista (inkluż diploppja)
English: - Furosemide and torasemide
Maltese: - Furosemide u torasemide
English: Myocardial infarction, arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation)
Maltese: Infart mijokardijaku, arritmija (inkluż bradikardija, takikardija talventrikolu, u fibrillazzjoni tal-atriju)
English: Angioedema, erythema multiforme, urticaria, exfoliative dermatitis, Stevens-Johnson syndrome, Quincke oedema, photosensitivity Musculoskeletal and connective tissue disorders Common
Maltese: Anġjoedima, eritema multiformi, urtikarja, dermatite esfoljattiva, is sindrome ta' Stevens-Johnson, edima Quincke, fotosensittività Disturbi muskolu-skeletriċi u tat-tessuti konnettivi Komuni
English: Pharmacotherapeutic group: Agents acting on the renin-angiotensin system, renin-inhibitors; ATC code C09XA54
Maltese: Sustanzi li jaħdmu fuq is-sistema tar-renin-angiotensin, inibituri tarrenin; Kodiċi ATC C09XA54
English: Tabulated list of adverse reactions:
Maltese: Lista ta' reazzjonijiet avversi miġbura f'tabella:
English: No interactions - Compounds that have been investigated in aliskiren clinical pharmacokinetic studies include acenocoumarol, atenolol, celecoxib, pioglitazone, allopurinol, isosorbide-5-mononitrate and hydrochlorothiazide.
Maltese: Bla interazzjonijieti - Komposti li kienu investigati fi studji ta' farmakokinetika klinika ta' aliskiren kienu jinkludu acenocoumarol, atenolol, celecoxib, pioglitazone, allopurinol, isosorbide-5-mononitrate u hydrochlorothiazide.
English: Linearity Amlodipine exhibits linear pharmacokinetics between the therapeutic dose range of 5 mg and 10 mg.
Maltese: Linearità Amlodipine juri farmakokinetika lineari fil-medda tad-doża terapewtika ta' bejn 5 mg u 10 mg.
English: • vision disorder (including double vision)
Maltese: • disturb fil-vista (inkluż vista doppja)
English: Study results indicated a hazard ratio for the primary endpoint of 1.11 in favour of placebo (95% Confidence Interval: 1.00, 1.23, 2-sided p=0.05).
Maltese: Riżultati ta' studji indikaw proporzjon ta' periklu għat-tragward finali primarju ta' 1.11 favur plaċebo (95% Confidence Interval: 1.00, 1.23, 2-sided p=0.05).
English: BLISTERS (CALENDAR) (PVC/PCTFE OR PA/Alu/PVC)
Maltese: FOLJI (KALENDARJU) (PVC/PCTFE JEW PA/Alu/PVC)
English: - Methyldopa
Maltese: ˗ Metildopa
English: Data reported in children below 6 years are limited.
Maltese: Dejta rrappurtata fi tfal ta' taħt is-6 snin hija limitata.
English: Respiratory distress (including pneumonitis and pulmonary oedema)
Maltese: Distress respiratorju (inkluż pulmonite u edima fil-pulmuni).
English: - CYP3A4 inducers
Maltese: - Indutturi ta' CYP3A4
English: - vitamin D and calcium salts.
Maltese: - vitamina D u mluħa tal-kalċju.
English: • itching; rash
Maltese: • ħakk; raxx
English: BLISTERS (PVC/PCTFE OR PA/Alu/PVC)
Maltese: FOLJI (PVC/PCTFE JEW PA/Alu/PVC)
English: Biotransformation and elimination
Maltese: Bijotransformazzjoni u eliminazzjoni
English: In particular there was an increased incidence of renal dysfunction (14.0% versus 12.1%), hyperkalaemia (38.9% versus 28.8%), hypotension-related events (19.7% versus 16.2%) and adjudicated stroke endpoints (3.4% versus 2.6%).
Maltese: B'mod partikulari kien hemm żieda fl-inċidenza ta' disfunzjoni renali (14.0% kontra 12.1%), iperkalemija (38.9% kontra 28.8%), episodji b'rabta ta' pressjoni baxxa (19.7% kontra 16.2%) u endpoints aġġudikati ta' puplesija (3.4% kontra 2.6%).
English: In addition, an increased incidence of adverse events was observed with aliskiren compared to placebo (37.9% versus 30.2%).
Maltese: Barra minn hekk, kienet osservata inċidenza akbar ta' episodji mhux mixtieqa b'aliskiren meta mqabbel ma' plaċebo (37.9% kontra 30.2%).
English: 98 tablets (2x49x1, PVC/PCTFE single-unit-dose blisters)
Maltese: 98 pillola (folji b'ħafna dożi singoli PVC/PCTFE, 2x49x1)
English: Aliskiren has been studied in 1,864 patients aged 65 years or older, and in 426 patients aged 75 years or older.
Maltese: Aliskiren kien studjat f'1,864 pazjent ta' etajiet minn 65 sena 'l fuq, u f'426 pazjent ta' etajiet minn 75 sena 'l fuq.
English: Severe renal impairment (GFR <30 ml/min/1.73 m Hyponatraemia, hypercalcaemia, symptomatic hyperuricaemia and refractory hypokalaemia.
Maltese: Indeboliment renali sever (GFR <30 ml/min/1.73 m Iponatremija, iperkalċemija, iperuriċemija sintomatika u ipokalemija refrattorja.
English: Approximately 1.4% of the total oral dose is metabolised.
Maltese: Madwar 1.4% tad-doża orali totali tiġi mmetabolizzata.
English: Name and address of the manufacturer responsible for batch release Novartis Farma S.p.A.
Maltese: Isem u indirizz tal-manifattur responsabbli għall-ħruġ tal-lott Novartis Farma S.p.A.
English: Hypertonia, peripheral neuropathy
Maltese: Ipertonja, newropatija periferali
English: Alopecia, purpura, skin decolouration, hyperhidrosis, pruritus, rash, exanthema
Maltese: Alopeċja, purpura, telf fil-kulur tal-ġilda, iperidrożi, ħakk, raxx, eksantema
English: The absolute bioavailability of aliskiren is approximately 2-3%.
Maltese: Il-bijodisponibbiltà assoluta ta' aliskiren hija madwar 2-3%.
English: - P-glycoprotein (P-gp) potent inhibitors
Maltese: - Inibituri potenti ta' glikoproteina P (P-gp)
English: The adverse reactions for aliskiren, amlodipine and hydrochlorothiazide are ranked under heading of frequency, the most frequent first, using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Maltese: Ir-reazzjonijiet avversi għal aliskiren, amlodipine u hydrochlorothiazide huma kklassifikati taħt it-titlu tal-frekweza, b'dak li jseħħ l-aktar frekwenti msemmi l-ewwel, bl-użu tal-konvenzjoni li ġejja: komuni ħafna (≥1/10); komuni (≥1/100 sa <1/10); mhux komuni (≥1/1,000 sa <1/100); rari (≥1/10,000 sa <1/1,000); rari ħafna (<1/10,000), mhux magħruf (ma tistax tittieħed stima mid-data disponibbli).
English: Amlodipine is extensively (approximately 90%) metabolised in the liver to inactive metabolites, with 10% of the parent compound and 60% of the metabolites excreted in the urine.
Maltese: Amlodipine huwa mmetabolizzat b'mod estensiv (madwar 90%) fil-fwied għal metaboli inattivi, b'10% tas-sustanza oriġinali u 60% tal-metaboliti jitneħħew mal-awrina.
English: Pancreatitis, gastritis, gingival hyperplasia
Maltese: Pankreatite, gastrite, iperplasja tal-ħniek
English: Among secondary endpoints, the incidence of heart failure (component of a composite combined cardiovascular endpoint) was significantly higher in the amlodipine group as compared to the chlorthalidone group (10.2% vs. 7.7%, RR 1.38, 95% CI [1.25-1.52] p<0.001).
Maltese: Fost it-tragwardi finali sekondarji, l-inċidenza ta' insuffiċjenza tal-qalb (komponent ta' taħlita komposta ta' tragward finali kardjovaskulari) kienet ogħla b'mod sinifikanti fil-grupp ta' amlodipine meta mqabbla mal-grupp ta' chlorthalidone (10.2% vs 7.7%, RR 1.38, 95% CI [1.25-1.52] p<0.001).
English: Not recommended - Lithium
Maltese: Mhux rakkomandat - Lithium
English: • severe allergic reaction (anaphylactic reaction)
Maltese: • reazzjoni allerġika gravi (reazzjoni anafilattika)
English: 56 tablets (PVC/PCTFE single-unit-dose blisters)
Maltese: 56 pillola (folji b'ħafna dożi singoli PVC/PCTFE)
English: PA/Alu/PVC - Alu calendar blisters: 18 months
Maltese: Folji kalendarju PA/Alu/PVC - Alu: 18-il xahar
English: Steady-state plasma levels are reached after continuous administration for 7-8 days.
Maltese: Livelli fil-plażma jilħqu stat fiss wara l-għotja kontinwa ta' 7-8 ijiem.
English: Rifampicin, which is an inducer of P-gp, reduced aliskiren bioavailability by approximately 50% in a clinical study.
Maltese: Rifampicin li huwa induttur ta' P-gp, naqqas il-bijodisponibbiltà ta' aliskiren b'madwar 50% fi studju kliniku.
English: Date of first authorisation: 22 November 2011 Date of latest renewal:
Maltese: Data tal-ewwel awtorizzazzjoni: 22 ta' Novembru 2011
English: Rasitrio is available in packs containing 56x1 tablet in perforated unit dose blister.
Maltese: Rasitrio huwa disponibbli f'pakketti li fihom 56x1 pilloli f'folji mtaqqbin b'ħafna dożi.
English: Unit dose pack (perforated unit dose blister) containing 56x1 tablet Multipacks of unit dose (perforated unit dose blister) containing 98x1 tablet (2 packs of 49x1)
Maltese: Pakkett b'dożi waħdiet (folja mtaqqba biex tinqata' doża waħda) li fihom 56x1 pillola Pakketti b'ħafna ta' dożi waħdiet (folja mtaqqba biex tinqata' doża waħda) li fihom 98x1 pillola (2 pakketti ta' 49x1)
English: - Warfarin The effects of aliskiren on warfarin pharmacokinetics have not been evaluated.
Maltese: - Warfarin L-effetti ta' aliskiren fuq il-farmakokinetika ta' warfarin ma kinux evalwati.
English: However, since aliskiren has been shown to be a substrate for the organic anion-transporting polypeptide 1A2 (OATP1A2) (see interaction with organic anion transporting polypeptide (OATP) inhibitors), there is a potential for aliskiren to reduce plasma torasemide exposure by an interference with the absorption process.
Maltese: Madankollu, peress li aliskiren intwera li huwa sottostrat għall-polipeptid 1A2 li jittrasporta lanjoni organiċi (OATP1A2) (ara l-interazzjoni ma' inibituri tal-polipeptid li jittrasporta l-anjoni organiċi (OATP - organic anion transporting polypeptide)), hemm potenzjal li aliskiren inaqqas lesponiment għal torasemide fil-plażma permezz ta' interferenza mal-proċess ta' assorbiment.
English: or an “angiotensin II receptor blocker” such as valsartan, telmisartan, irbesartan etc.
Maltese: jew - “imblukkatur tar-riċetturi ta' angiotensin II” bħal valsartan, telmisartan, irbesartan, eċċ.
English: Aliskiren plasma protein binding is moderate (47-51%) and independent of the concentration.
Maltese: Ir-rabta mal-proteini fil-plażma ta' aliskiren hija moderata (47-51%) u ma tiddependix fuq il-konċentrazzjoni.
English: - Co-administration of aliskiren with either metformin (↓28%), amlodipine (↑29%) or cimetidine (↑19%) resulted in between 20% and 30% change in Cmax or AUC of aliskiren.
Maltese: - Meta aliskiren jingħata ma' metformin (↓28%), amlodipine (↑29%) jew cimetidine (↑19%) isCmax jew AUC ta' aliskiren inbidlu b'bejn 20% u 30%.
English: - clarithromycin, telithromycin, erythromycin which are antibiotics used to treat infections.
Maltese: - clarithromycin, telithromycin, erythromycin li huma antibijotiċi li jintużaw biex jikkuraw infezzjonijiet.
English: Rasitrio is available in packs containing 14, 28, 56, 98 tablets in calendar blisters.
Maltese: Rasitrio huwa wkoll disponibbli f'pakketti li fihom 14, 28, 56, 98 pillola f'folji bil-kalendarju.
English: Single pack containing 30, 90 tablets
Maltese: Pakkett wieħed li fih 30, 90 pillola
English: - amiodarone, a medicine used to treat abnormal heart rhythms.
Maltese: - amiodarone, mediċina li tintuża biex tikkura ritmu tal-qalb mhux normali.